J Mov Disord.
2025 Apr;18(2):179-181. 10.14802/jmd.24247.
Levodopa Pharmacokinetics in Switching From Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson’s Disease: A Case Report
- Nukariya T
1,2,3 - Tezuka T1,2,3
- Okusa S1,2,3
- Okochi R1,2,3
- Sakai Y1,2,3
- Nihei Y1,2,3
- Nakahara J1,2,3
- Seki M1,2,3
- Affiliations
-
- 1Department of Neurology, Keio University School of Medicine, Tokyo, Japan
- 2Parkinson’s Disease Center, Keio University Hospital, Tokyo, Japan
- 3Center for Parkinson's disease Research, Keio University, Tokyo, Japan
- KMID: 2567165
- DOI: http://doi.org/10.14802/jmd.24247
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Potential Psychosis Induced by a Sustained High Plasma Levodopa Concentration Due to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson’s Disease: A Case Report
- Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose
- Liquid Levodopa/Carbidopa: Old Solution, Forgotten Complication
- An Anesthetic Management of a Patient with Parkinson's Disease Who Underwent Whipple's Operation by Enteral Levodopa Administration
- A Case of Dopamine Dysregulation Syndrome and Repetitive Behavior Caused by Levodopa in Parkinson's Disease
